ahlam1399
07-27-2016, 11:20 AM
GlaxoSmithKline invests $360 million in post-Brexit UK manufacturing
LONDON (Reuters) - GlaxoSmithKline plans 275 million pounds ($361 million) of new investments at three drug manufacturing sites in Britain, signaling its confidence in the country despite last month's vote to leave the European Union.http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=2weliP9_WGw:556oRVviN_g:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=2weliP9_WGw:556oRVviN_g:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=2weliP9_WGw:556oRVviN_g:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=2weliP9_WGw:556oRVviN_g:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=2weliP9_WGw:556oRVviN_g:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/2weliP9_WGw
LONDON (Reuters) - GlaxoSmithKline plans 275 million pounds ($361 million) of new investments at three drug manufacturing sites in Britain, signaling its confidence in the country despite last month's vote to leave the European Union.http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=2weliP9_WGw:556oRVviN_g:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=2weliP9_WGw:556oRVviN_g:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=2weliP9_WGw:556oRVviN_g:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=2weliP9_WGw:556oRVviN_g:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=2weliP9_WGw:556oRVviN_g:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/2weliP9_WGw